Compositions and methods for treating metabolic disorders
US10603291B2 · kind B2 · utility
4Cited by
36References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2017 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Sep 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.